Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous, non-small cell lung cancer: TORG (thoracic oncology research group) 1321.
Kasai T, Mori K, Nakamura Y, Seki N, Ichikawa Y, Saito H, Kondo T, Nishikawa K, Otsu S, Bessho A, Tanaka H, Yamaguchi H, Kaburagi T, Imai H, Mori K, Ohtake J, Okamoto H. Kasai T, et al. Among authors: kaburagi t. Cancer Med. 2023 Jul;12(14):14988-14999. doi: 10.1002/cam4.6135. Epub 2023 May 24. Cancer Med. 2023. PMID: 37226421 Free PMC article. Clinical Trial.
Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809.
Niho S, Ikeda N, Michimae H, Suzuki K, Sakai H, Kaburagi T, Minato K, Kato T, Okamoto H, Seto T, Hosomi Y, Shimizu K, Oshita F, Kunitoh H, Tsuboi M, Takeuchi M, Watanabe K. Niho S, et al. Among authors: kaburagi t. Br J Cancer. 2013 Aug 6;109(3):545-51. doi: 10.1038/bjc.2013.378. Epub 2013 Jul 18. Br J Cancer. 2013. PMID: 23868010 Free PMC article. Clinical Trial.
A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients.
Imai H, Sugiyama T, Tamura T, Minemura H, Kaira K, Kanazawa K, Yokouchi H, Kasai T, Kaburagi T, Minato K; Gunma-Ibaraki-Fukushima-Tochigi (GIFT) group. Imai H, et al. Among authors: kaburagi t. Cancer Chemother Pharmacol. 2017 Sep;80(3):615-622. doi: 10.1007/s00280-017-3403-9. Epub 2017 Jul 31. Cancer Chemother Pharmacol. 2017. PMID: 28761968 Free PMC article.
Overall Survival Results of the Feasibility Study of Adjuvant Chemotherapy With Docetaxel Plus Cisplatin Followed by Long-term Single-agent Administration of S-1 in Patients With Completely Resected Non-Small Cell Lung Cancer: Thoracic Oncology Research Group (TORG) 0809.
Niho S, Ikeda N, Michimae H, Suzuki K, Sakai H, Kaburagi T, Yoshiya K, Minato K, Kato T, Okamoto H, Seto T, Hosomi Y, Shimizu K, Saito H, Tsuchida M, Kunitoh H, Tsuboi M, Takeuchi M, Watanabe K. Niho S, et al. Among authors: kaburagi t. Am J Clin Oncol. 2018 Nov;41(11):1113-1117. doi: 10.1097/COC.0000000000000438. Am J Clin Oncol. 2018. PMID: 29521649
Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR-TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations.
Imai H, Minemura H, Sugiyama T, Yamada Y, Kaira K, Kanazawa K, Kasai T, Kaburagi T, Minato K; Gunma-Ibaraki-Fukushima-Tochigi (GIFT) Group. Imai H, et al. Among authors: kaburagi t. Cancer Chemother Pharmacol. 2018 Jul;82(1):119-127. doi: 10.1007/s00280-018-3596-6. Epub 2018 May 8. Cancer Chemother Pharmacol. 2018. PMID: 29737372
Clinical Impact of Post-Progression Survival on Overall Survival in Elderly Patients with Non-Small-Cell Lung Cancer Harboring Sensitive EGFR Mutations Treated with First-Line EGFR Tyrosine Kinase Inhibitors.
Imai H, Yamada Y, Sugiyama T, Minemura H, Kaira K, Kanazawa K, Kasai T, Kaburagi T, Minato K; Gunma-Ibaraki-Fukushima-Tochigi (GIFT) group. Imai H, et al. Among authors: kaburagi t. Chemotherapy. 2018;63(3):181-189. doi: 10.1159/000490949. Epub 2018 Aug 14. Chemotherapy. 2018. PMID: 30107372
Topotecan monotherapy for the treatment of relapsed small cell lung cancer in elderly patients: A retrospective analysis.
Imai H, Yamada Y, Minemura H, Sugiyama T, Kotake M, Kaira K, Kanazawa K, Nakamura Y, Kasai T, Shibata Y, Kaburagi T, Minato K; Gunma-Ibaragi-Fukushima-Tochigi (GIFT) Group. Imai H, et al. Among authors: kaburagi t. Thorac Cancer. 2018 Dec;9(12):1699-1706. doi: 10.1111/1759-7714.12884. Epub 2018 Oct 3. Thorac Cancer. 2018. PMID: 30281216 Free PMC article.
A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer -TCOG 1101.
Kasai T, Mori K, Kishi K, Kaburagi T, Hosomi Y, Imai H, Yamada Y, Yomota M, Moriguchi S, Seike M, Minato K, Gemma A; Tokyo Cooperative Oncology Group. Kasai T, et al. Among authors: kaburagi t. Int J Clin Oncol. 2020 May;25(5):867-875. doi: 10.1007/s10147-020-01629-6. Epub 2020 Feb 14. Int J Clin Oncol. 2020. PMID: 32060768 Clinical Trial.
154 results